Founded in 2009, SOM Biotech is a global leader in drug repurposing for rare diseases. With a strong pipeline focused on CNS disorders, including Huntington's disease and Adrenoleukodystrophy, SOM is headquartered in Barcelona and Cambridge, MA.
National Ranking2474th
in Spain Regional Ranking27465th
in Western Europe Global Ranking108845th
worldwide Rankings by
